Status:
COMPLETED
Cystic Fibrosis and Cognitive Function
Lead Sponsor:
University of Minnesota
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The long-term goal of this project is to examine the effects of cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD) on brain structure and function
Detailed Description
A growing body of evidence suggests that hyperglycemia in type 1 and type 2 diabetes is associated with alterations in brain structure and cognitive impairment. People with cystic fibrosis related dia...
Eligibility Criteria
Inclusion
- patients with Cystic fibrosis
Exclusion
- History of stroke
- History of epilepsy
- History of neurosurgical procedures
- Past or current history of severe psychiatric illness
- Pass or current history of alcohol or substance abuse
- Presence of metallic substances in body or inability to remove before imaging procedure
- History of claustrophobia or known inability to tolerate MRI
- Current pregnancy
- Inability to consent
Key Trial Info
Start Date :
May 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03820349
Start Date
May 7 2018
End Date
December 10 2019
Last Update
July 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical and Translational Science Institute and Center for Magnetic Resonance Research, University of Minnesota
Minneapolis, Minnesota, United States, 55455